Cargando…
Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333260/ https://www.ncbi.nlm.nih.gov/pubmed/32616069 http://dx.doi.org/10.1186/s13075-020-02257-1 |
_version_ | 1783553713602822144 |
---|---|
author | Emery, Paul Tanaka, Yoshiya Cardillo, Tracy Schlichting, Douglas Rooney, Terence Beattie, Scott Helt, Cameron Smolen, Josef S. |
author_facet | Emery, Paul Tanaka, Yoshiya Cardillo, Tracy Schlichting, Douglas Rooney, Terence Beattie, Scott Helt, Cameron Smolen, Josef S. |
author_sort | Emery, Paul |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7333260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73332602020-07-06 Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis Emery, Paul Tanaka, Yoshiya Cardillo, Tracy Schlichting, Douglas Rooney, Terence Beattie, Scott Helt, Cameron Smolen, Josef S. Arthritis Res Ther Correction BioMed Central 2020-07-02 2020 /pmc/articles/PMC7333260/ /pubmed/32616069 http://dx.doi.org/10.1186/s13075-020-02257-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Emery, Paul Tanaka, Yoshiya Cardillo, Tracy Schlichting, Douglas Rooney, Terence Beattie, Scott Helt, Cameron Smolen, Josef S. Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title | Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title_full | Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title_fullStr | Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title_full_unstemmed | Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title_short | Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
title_sort | correction to: temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333260/ https://www.ncbi.nlm.nih.gov/pubmed/32616069 http://dx.doi.org/10.1186/s13075-020-02257-1 |
work_keys_str_mv | AT emerypaul correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT tanakayoshiya correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT cardillotracy correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT schlichtingdouglas correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT rooneyterence correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT beattiescott correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT heltcameron correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis AT smolenjosefs correctiontotemporaryinterruptionofbaricitinibcharacterizationofinterruptionsandeffectonclinicaloutcomesinpatientswithrheumatoidarthritis |